Terns Pharma is due to release data from an early-stage trial of an obesity treatment in pill form in the second half. Positive data would send the stock higher.
This small-cap stock is expected to take off — if its weight-loss pill trial succeeds
Read Next
- If you want people to start genuinely enjoying your company, say goodbye to these 7 behaviors
- Senate review of Supreme Court ethics urges enforceable conduct code
- 9 signs someone isn’t actually nice, they’re a just a people-pleaser
- 6 types of family members who can be very difficult to live with, according to psychology
- If you really want to overcome your difficult childhood, say goodbye to these 7 habits
- HDFC Securities expects India GDP to moderate to 6.4% in 2024-25, ET BFSI
- House Democrats say GOP caved to Elon Musk, protecting China interests
